Multimodality Neuromonitoring in XLIF

NCT01499680 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 323

Last updated 2025-12-24

No results posted yet for this study

Summary

This is a prospective, non-randomized multi-center study to evaluate intraoperative neuromonitoring results in subjects who undergo eXtreme Lateral Interbody Fusion (XLIF) surgery at any number of levels inclusive of L4-5.

Conditions

  • Degeneration of Lumbar Intervertebral Disc

Sponsors & Collaborators

  • NuVasive

    lead INDUSTRY

Principal Investigators

  • Kelli Howell, MS · NuVasive

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-12-31
Completion
2014-06-30

Countries

  • United States
  • Puerto Rico
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01499680 on ClinicalTrials.gov